aTyr Pharma Investors

25 investors on Angel Roster list aTyr Pharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name aTyr Pharma can appear together.

Investors listed
25
With verified email
56%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 25 aTyr Pharma investors

The most complete profiles first. Showing 25 of 25.

  • Brian HalakVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 61 more

    Verified email available

  • James BlairVerified

    Venture Capital, Investor · United States

    SeedBiotechnologyPharmaceuticals

    Portfolio: Zogenix, Gene Sciences, Inc., Astute Medical, Ocunexus Therapeutics and 8 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Eckard WeberVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • JOHN CLARKEVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jim BlairVerified

    Venture Capital · United States

    Health CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Oleg NodelmanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Rob FaulknerVerified

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Sarah MarriottVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Scott PlatshonVerified

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Verified email available

  • Tom McKinleyVerified

    Micro VC · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Melinta, Cureatr, AxoGen, Verastem Oncology and 24 more

    Verified email available

  • Amir Nashat

    Venture Capital, Angel/Individual, Investor · United States

    SeedPre-SeedEnergyBiotechnologyElectronic Health Records (EHR)Health and Hospital Services

    Portfolio: Athenix, AgBiome, BIND Therapeutics, Jnana Therapeutics and 15 more

    Contact details available

  • Jesse Treu

    Venture Capital, Founder, Investor · United States

    SeedHealth CareWellnessWomen FoundedLife Science

    Portfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 55 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Pete Hudson, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsGeneticsWomen Founded

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Bob More

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lassen Therapeutics, Avid Radiopharmaceuticals, Nereus Pharmaceuticals, Calistoga Pharmaceuticals and 59 more

    Contact details available

  • Caroline Stout

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementAndroidLife Science

    Portfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more

    Contact details available

  • Gerard van Hamel Platerink

    Hedge Fund, Venture Capital, Private Equity Firm · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

Frequently asked questions

How many aTyr Pharma investors are on Angel Roster?

Angel Roster lists 25 aTyr Pharma investors. 14 of them (56%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (8) and Hedge Funds (4). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do aTyr Pharma investors invest in?

Among those that list a stage, the most common are Seed (9), Series B (1) and Pre-Seed (1).

Where are aTyr Pharma investors based?

Most are based in the United States (24) and Canada (1).

Which companies have aTyr Pharma investors backed?

The most-backed portfolio companies among them are Iterum Therapeutics (13), Akouos (13), ZS Pharma (11), First Aid Shot Therapy (11) and Audentes Therapeutics (11).

How do I contact aTyr Pharma investors?

Create a free Angel Roster account to search and filter all 25, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.